Elevated serum β-d-glucan levels in cavitary pulmonary nocardiosis

2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

An 86-year-old woman with Borrmann type III colorectal cancer (Union for International Cancer Control pT4aN2bM1c, pStage IVc) had received dexamethasone for the last 6 months as palliative care. She presented with a low-grade fever, chest pain and cough. Chest radiography on admission showed cavities and consolidations bilaterally in the upper lobes. A blood examination on admission revealed highly elevated serum β-d-glucan levels. The diagnosis by bronchoscopy was pulmonary nocardiosis. With trimethoprim/sulfamethoxazole and imipenem/cilastatin, the β-d-glucan levels were decreased, and chest X-ray showed improvement after 1 month. β-d-glucan is known to be a biomarker of fungal infection. It is possible that β-d-glucan levels also indicate a pulmonary infection by Nocardia.

Cite

CITATION STYLE

APA

Yagyu, K., Nakatsuji, Y., & Matsushita, H. (2020). Elevated serum β-d-glucan levels in cavitary pulmonary nocardiosis. BMJ Case Reports, 13(7). https://doi.org/10.1136/bcr-2020-234738

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free